Longeveron, Inc. (LGVN)
0.7799
+0.03
(+3.44%)
USD |
NASDAQ |
Jun 09, 16:00
0.7799
0.00 (0.00%)
After-Hours: 19:15
Longeveron EPS Diluted (Quarterly) : -0.1911 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| HCW Biologics Inc. | 0.3657 |
| Arrowhead Pharmaceuticals, Inc. | -0.932 |
| Oncolytics Biotech, Inc. | -0.0823 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | 2.878 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.736M |
| Revenue (Quarterly) | 0.398M |
| Total Expenses (Quarterly) | 5.134M |
| Enterprise Value | 8.198M |
| Gross Profit Margin (Quarterly) | 3.02% |
| Profit Margin (Quarterly) | -1.19K% |
| Earnings Yield | -148.3% |
| Normalized Earnings Yield | -148.28 |